The race to find a new treatment for hair loss hotted up last month with two mega funding rounds for Pelage Pharmaceuticals ...

US pharma major Bristol Myers Squibb—in collaboration with Johnson & Johnson—has announced the decision to stop the Phase III ...

TandemAI has announced that it has secured a $22 million Series A extension to further develop its drug discovery platform, ...

Merck & Co has struck a $9.2 billion deal to acquire biotechnology company Cidara Therapeutics in a move that bolsters the US ...

Ireland-based Avadel Pharmaceuticals today announced that it has received an unsolicited proposal from Denmark’s Lundbeck to ...

The US Food and Drug Administration approved USA-based Kura Oncology and Japan’s Kyowa Kirin’s ziftomenib (trade name ...

US medtech firm Terumo Blood and Cell Technologies has appointed Liza Loidolt as general manager of its cell and gene therapy ...

Gate Bioscience has raised $65 million in an oversubscribed series B to advance its first molecular gate candidates, a novel ...

UK-based life sciences venture capital firm Medicxi today announced the closing of Medicxi V, a 500 million-euros ($579.5 ...

German generics and consumer healthcare major STADA Arzneimittel has appointed Craig Shaw as its general manager in the UK.

The pharma trade group the Association of the British Pharmaceutical Industry (ABPI) and the UK government have agreed to a ...

Chinese biotech Biokin Pharmaceutical (SHA: 688506) has postponed its planned Hong Kong share listing, citing “prevailing ...